Analysts at Goldman Sachs upgrade Onyx Pharma (NASDAQ: ONYX) from "neutral" to "buy." The target price for ONXX has been raised from $34 to $37.
ONXX’s shares closed at $31.50 yesterday. More Analyst Ratings here
From novice to pro, Chart-Caster delivers over $11,000 per month* in profitable trade setups across all time-frames from which members can evaluate, select, and replicate within their own trading accounts.
This product is for individuals looking to generate a cash payout/yield from cash left within a brokerage account.
Options & Volatility Edge is for those people who want to make money using cost effective options trading strategies. This product is for anyone—novices and experts. If you understand how to enter an options trade, you need Options & Volatility Edge.
The ETF Professor is truly an appropriate moniker, because the Professor spends hours everyday analyzing the charts of dozens of ETFs EVERY DAY.
Winning Stocks Under Five Dollars tracks and analyzes attractive stocks that are currently trading below $5. Investors receive information on inexpensive companies that have the potential to beat the market.
In this game, information is everything. You have to know what is happening before the Street begins trading against you utilizing the new information. We will provide you with that edge.
Risking a Dollar To Make Five
Stephen Eubanks: Equities Continue Moving but the Rubber Band is...
This Week With Tradersaudio's Lichtenstein: Opportunity in the...
CNBC's Joe Terranova: Only Ones Disappointed in Jobs Number are...
Are the S&P and NasDaq Over-leveraged? MrTopStep's Stephen...
TradersAudio's Lichtenstein: Money Is Moving and I'm...
CNBC's Joe Terranova Bullish On Tech Sector Equities Google, IBM...
What's Next in US Macro? Q4 GDP Breakdown with Citi's...
Stephen Eubanks: How Long Does the Disbelief Rally Last?
The Overnight Gold Trade That is Up 1700% Since 2001: Sam Kirtley of...
OpCo's Fadel Gheit: Why Q4 Refiner Earnings Will Be Lower and...
Special Offers:
Quick Cash Advance
1.877.440.ZING (9464)
